MedClub by Dr. Jenn has been offering Testosterone Replacement Therapy and Performance Medicine for Men in West Palm Beach for over 10 years. This isn’t a simple, one-size-fits-all subject — there are many individual factors that come into play. Below we’ll walk through the basics; if you’d like to find out whether TRT may be right for you, contact us anytime to schedule an in-person consultation. TRT at MedClub is offered exclusively in person — this program is not available through telemedicine, and we do not treat female hormones.
Hormones affect every part of the body, including how it stores fat. Every man needs some estrogen, regardless of age — estrogen plays a role in sperm production, cardiovascular health, and bone strength. But when estrogen levels run too high, it can contribute to unwanted symptoms and frustration with body composition. In men, the primary form of estrogen is estradiol (E2), which is one of the key markers we test as part of hormone evaluation. Elevated estrogen is associated with increased activity of certain receptors on subcutaneous fat cells (alpha-2A adrenergic receptors), which may make it harder for the body to break down fat stored just beneath the skin.
Compounding this, fat cells themselves contain an enzyme called aromatase, which converts testosterone into estrogen. This creates a cycle where elevated estrogen can make it more difficult to reduce subcutaneous fat, and that same fat tissue can, in turn, contribute to further estrogen production. This cycle is often difficult to interrupt without medical support. Common signs of estrogen imbalance aren’t about developing feminine characteristics — more often, they show up as difficulty seeing muscle definition despite consistent training, or diet and exercise not producing the results you’d expect.
This is a common and completely fair question, and we’re not here to judge anyone’s past choices — what matters is doing things safely and correctly going forward.
The core difference comes down to dosing intent. TRT is prescribed to restore your testosterone to a normal, healthy physiological range based on your bloodwork — the goal is balance, not enhancement. Steroid “cycles” typically involve supraphysiologic doses (well above what your body naturally produces) for a defined period, often without medical supervision or monitoring, which is where most of the associated risks come from.
We regularly see patients who used steroids in the past and are now concerned about fertility, testicular atrophy, symptoms of gynecomastia, or low testosterone from an improperly managed post-cycle transition. It’s worth being direct about one thing: TRT itself, like steroid use, can suppress your body’s natural testosterone production and affect fertility while you’re on treatment — this isn’t unique to “juicing.” A responsible TRT protocol accounts for this, monitors for it, and can incorporate additional medications when appropriate to help manage this effect. This is exactly why individualized dosing, real bloodwork, and physician oversight matter — we don’t use one-size-fits-all protocols, and we tailor treatment for patients with diabetes, cardiovascular conditions, and older patients as well, factoring in each patient’s full health picture.
If you already have recent bloodwork, your initial consultation is $150. If you need labs done, you'll prepay $300 upfront, and we'll send you to a Quest Diagnostics draw center for your blood draw — no insurance required. Once your results are in, you'll sit down with your provider to review them and build your treatment plan together. That $300 covers your labs, consultation, training, and your first month of treatment. After that, an $89/month membership covers ongoing physician oversight; you pay for your medication separately, directly at the pharmacy of your choice.
Medication cost depends on the type and dosage prescribed, and is paid directly to your pharmacy, separate from your MedClub membership. Your provider can give you a more specific estimate based on your treatment plan.
No. There is no contract with a MedClub membership, and you may cancel at any time for any reason. A titration schedule will be provided if needed at the time of cancellation. Cancellations can be made by phone or email before your next billing cycle.
Many patients combine services across different areas — for example, pairing peptide therapy with TRT, or adding ED treatment to an existing testosterone program. When you combine services, we can often offer a discounted rate across your membership tiers.
No, we do not accept insurance. Our consultation, lab, and membership pricing is self-pay, with no insurance required at any step — including your lab draw at Quest Diagnostics.
No. Because testosterone is a controlled substance, TRT at MedClub requires an in-person evaluation and is only offered to patients who visit our West Palm Beach clinic. We do not treat female hormones through this program.
Testosterone therapy carries potential risks, including an increased risk of blood clots, elevated red blood cell count (polycythemia) requiring periodic monitoring, potential effects on fertility and natural testosterone production while on treatment, and considerations related to prostate health and cardiovascular risk factors. TRT is not appropriate for everyone, and your provider will review your complete health history and bloodwork before and throughout treatment to monitor for these effects. Compounded medications referenced above are not FDA-approved.
The information above is provided for general educational purposes and is not a substitute for professional medical advice, diagnosis, or treatment. Individual results vary and are not guaranteed. Eligibility for treatment is determined solely by the prescribing provider following an individual, in-person medical evaluation. This page does not create a doctor-patient relationship. The statements made on this page have not been evaluated or approved by the FDA.
Testosterone replacement isn't the only option for men looking to address low testosterone symptoms. For men who aren't ready to start full TRT — often because they want to preserve fertility or avoid suppressing their body's own hormone production — HCG or enclomiphene/clomiphene monotherapy may be a reasonable starting point to discuss with your provider.
HCG (Pregnyl®/Novarel®) — Off-Label Use
HCG is FDA-approved for other indications, but is commonly used off-label to stimulate the body's own testosterone production by mimicking luteinizing hormone (LH), which signals the testes directly. Clinical research shows HCG can improve testosterone levels, symptoms, and sperm parameters in appropriate candidates, and it's recognized by American Urological Association guidelines as an alternative to TRT for men who want to preserve fertility(1).
Enclomiphene / Clomiphene
Enclomiphene and clomiphene work differently than HCG — they block estrogen receptors in the brain, which signals your body to increase its own natural testosterone production rather than replacing it directly. A systematic review of clinical trials found this approach significantly raised total testosterone, LH, and FSH levels compared to placebo, with effects on testosterone comparable to topical testosterone gel(2). Because this approach preserves the body's natural hormone signaling rather than suppressing it, it's considered a fertility-sparing option worth discussing if that's a priority for you(3).
These approaches are generally used in men with functional or secondary hypogonadism and are not appropriate for every patient. Your provider will determine, based on your bloodwork and health history, whether monotherapy is a reasonable starting point or whether full TRT is more appropriate for your situation.
1. British Society of Sexual Medicine: Position Statement for the Potential Use of Enclomiphene in the Treatment of Male Hypogonadism, PMC, 2026.
2. Clomiphene or Enclomiphene Citrate for the Treatment of Male Hypogonadism: A Systematic Review and Meta-Analysis of RCTs, PMC, 2026.
3. Pituitary Axis Impacts and Effectiveness of Clomiphene and Human Chorionic Gonadotropin in Treating Hypogonadism: Cohort Study, PubMed, 2026.